Log in to save to my catalogue

Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of...

Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_32a58dbb051a4ad7b6e1bcff02b3c19d

Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017

About this item

Full title

Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017

Publisher

United States: U.S. National Center for Infectious Diseases

Journal title

Emerging infectious diseases, 2020-11, Vol.26 (11), p.2660-2668

Language

English

Formats

Publication information

Publisher

United States: U.S. National Center for Infectious Diseases

More information

Scope and Contents

Contents

To prevent invasive pneumococcal disease (IPD), pneumococcal conjugate vaccines (PCVs) have been implemented in many countries; however, many cases of IPD still occur and can be attributable to nonvaccine serotypes of Streptococcus pneumoniae. In Japan, the number of IPD cases attributable to serotype 12F increased from 4.4% in 2015 to 24.6% in 201...

Alternative Titles

Full title

Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_32a58dbb051a4ad7b6e1bcff02b3c19d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_32a58dbb051a4ad7b6e1bcff02b3c19d

Other Identifiers

ISSN

1080-6040

E-ISSN

1080-6059

DOI

10.3201/eid2611.200087

How to access this item